Published • loading... • Updated
Insulet sales grow 34% in Street-beating Q1, guidance raised
Summary by Drug Delivery Business
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Insulet sales grow 34% in Street-beating Q1, guidance raised
Insulet (Nasdaq:PODD) today reported first-quarter financial results that came in well ahead of the consensus forecast on Wall Street. Shares of PODD ticked up 5% to $175.79 before the market opened today. The Acton, Massachusetts-based automated insulin pump developer reported profits of $91.1 million. That equals $1.30 per share on sales of $761.7 million for the three months ended March 31, 2026. Insulet recorded a significant bottom-line gai…
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
